COLUMBIA, Md., Sept. 13 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it is presenting at the upcoming UBS Global Life Sciences Conference in New York City. The conference is being held September 24-27, 2007 at the Grand Hyatt in New York. Peter L. Buzy, CFO will be presenting on Tuesday, September 25th at 3:00 p.m. Eastern Time.
A live audio webcast of Martek's presentation can be accessed at: http://events.streamx.us/us/event/eventdetails.aspx?id=ubs20070924
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Contact: Kyle Stults
|SOURCE Martek Biosciences Corporation|
Copyright©2007 PR Newswire.
All rights reserved